Table GPS-8. Lifetime prevalence of drug use among all adults (aged 15 to 64) in nationwide surveys among the general population – Part (ii) Survey methods: last survey available for each Member State

Country

geographical area

Year

Ref.

Collection method

Original Age range

Original sample size

Age range all adults

Sample size all adults

Age range young adults

Sample size young adults

Belgium

National

2001

(5)

Interview

15-64

9470

15-64

7347

15-34

2758

Czech Republic

National

2004

(2)

Interview

18-64

3526

18-64

3526

18-34

1414

Denmark

National

2000

(3)

Interview

16+

14278

16-64

11825

16-34

4141

Germany

National

2003

(6)

Mail

18-59

8061

18-59

8061

18-34

3775

Estonia

National

2003

(2)

Mail

15-69

1891

15-64

 

 

646

Greece

National (except Aegean and Ionian Islands)

2004

(3)

Interview

12-64

4781

15-64

4351

15-34

2620

Spain

National

2003

(5)

Interview

15-64

12033

15-64

12033

15-34

5357

France

Metropolitan France

2002

(5)

Phone

15-75

2009

15-64

1744

15-34

724

Ireland

National

2002-03

(4)

Interview

15-64

4918

15-64

4918

15-34

 

Italy

National

2003

(2)

Mail

15-54

34489

15-54

11869

15-34

5231

Cyprus

National

2003

(1)

Interview

15-65

90.9

15-65

1000

15-34

580

Latvia

National

2003

(1)

Interview

15-64

4534

15-64

4534

15-34

 

Lithuania

National

2004

(1)

Interview

15-64

4207

15-64

4207

15-34

1814

Luxembourg

National

1998

(1)

Interview

12-64

667

15-64

 

15-34

 

Hungary

National

2003

(2)

Interview

18-54

3675

18-54

 

18-34

2319

Malta

National

2001

(1)

Interview

18-64

2828

18-64

1755

18-34

640

Netherlands

National

2001

(2)

Multimethod

12+

17655

15-64

14045

15-34

6687

Austria

National

2004

(1)

Interview

14-100

4547

15-64

3980

15-34

1754

Poland

National

2002

(1)

Interview

16+

3148

16-64

 

16-34

 

Portugal

National

2001

(1)

Interview

15-64

14186

15-64

14186

15-34

6406

Slovakia

National

2004

(2)

Interview

15-64

1315

15-64

1315

15-34

578

Finland

National

2004

(6)

Mail

15-69

2526

15-64

2352

15-34

1031

Sweden

National

2005

(6)

Mail

16-84

40002

16-64

30538

16-34

9522

United Kingdom

England and Wales

2004-05

(8)

Interview

16-59

28509

16-59

28509

16-34

9913

United Kingdom

Northern Ireland

2002-03

(9)

Interview

15-64

3516

15-64

3516

15-34

 

United Kingdom

Scotland

2003

(10)

Interview

16+

4665

16-64

3506

16-34

1193

United Kingdom

United Kingdom

2004

(11)

Interview

 

35707

 

35707

16-34

 

Bulgaria

National

2005

(1)

Interview

18-60

1036

18-60

1036

18-34

433

Romania

National

2004

(1)

Interview

15-64

 

15-64

 

15-34

 

Norway

National

1999

(1)

Interview

15+

2170

15-64

1803

15-34

794

Notes:

This table aims to provide an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as a reference point for the 1993 survey.

'Data collection' means 'data collection method used in the survey': 'interview.' (face to face interview), 'phone' (telephone interview), 'mail' (mailed questionnaire), 'Multimethod' (Multi-Method - interview, mail or internet).

Survey sample' refers to number of actual respondents to survey (Net sample). In some cases, national surveys cover originally a broader age range ('original age range') than that presented here for the standard groups 'All adults'(15-64) and 'Young adults' (15-34). Sample sizes are presented respectively for the 'original age range', the 'all adults' and 'young adults' groups.

In surveys with small sample sizes results should be interpreted with caution.

Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15 to 64, young adults: 15 to 34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher.

For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

See Table GPS-0.

Data filter | gpstab09b-en.xml